Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RPS16 |
| Upstream (Parents) |
|---|
| (<<) DYNLL1 → RPS16 |
| (<<) ELOVL1 → RPS16 |
| (<<) HSP90AA1 → RPS16 |
| (<<) HSPA8 → RPS16 |
| (<<) MAP2K3 → RPS16 |
| (<<) PGK1 → RPS16 |
| (<<) RHOA → RPS16 |
| (<<) RNF111 → RPS16 |
| (<<) RPS12 → RPS16 |
| (<<) SEPW1 → RPS16 |
| (<<) SET → RPS16 |
| (<<) TSC22D1 → RPS16 |
| Downstream (Children) |
|---|
| RPS16 → ACTG1 (>>) |
| RPS16 → AKT1 (>>) |
| RPS16 → ALDOA (>>) |
| RPS16 → ATIC (>>) |
| RPS16 → CDKN2A (>>) |
| RPS16 → CFL1 (>>) |
| RPS16 → CLPP (>>) |
| RPS16 → DUSP6 (>>) |
| RPS16 → GPX1 (>>) |
| RPS16 → GRK5 (>>) |
| RPS16 → GRK6 (>>) |
| RPS16 → GRPEL1 (>>) |
| RPS16 → HDAC3 (>>) |
| RPS16 → INPPL1 (>>) |
| RPS16 → KHDRBS3 (>>) |
| RPS16 → LAMB2 (>>) |
| RPS16 → MAP3K14 (>>) |
| RPS16 → MBOAT2 (>>) |
| RPS16 → MYC (>>) |
| RPS16 → NNMT (>>) |
| RPS16 → NXT1 (>>) |
| RPS16 → PAK6 (>>) |
| RPS16 → PDK1 (>>) |
| RPS16 → PKM2 (>>) |
| RPS16 → PLK3 (>>) |
| RPS16 → RAD51L3 (>>) |
| RPS16 → RPL26L1 (>>) |
| RPS16 → RPL35 (>>) |
| RPS16 → RPL36 (>>) |
| RPS16 → RRP9 (>>) |
| RPS16 → TINF2 (>>) |
| RPS16 → TPM4 (>>) |
| RPS16 → TPSG1 (>>) |
| RPS16 → TUBA1B (>>) |
| RPS16 → TUBA1C (>>) |
| RPS16 → YWHAB (>>) |
